Services
Company
Legal and Governance
Publication Library / Publications
Treatment patterns and economic burden among newly diagnosed cervical and endometrial cancer patients
Aim
This study evaluated treatment patterns, healthcare resource use and healthcare costs among newly diagnosed US patients with cervical or endometrial cancer.
Materials & methods
The authors identified patients diagnosed between 2015 and 2018, described them by line of therapy (LOT), then summarized all-cause per patient per month healthcare resource use and healthcare costs per LOT.
Results
Among 1004 patients with cervical cancer and 2006 patients with endometrial cancer, 65.2 and 71.4%, respectively, received at least LOT1. Common treatment modalities in LOT1 were surgery (cervical, 58.0%; endometrial, 92.6%), radiation therapy (cervical, 49.8%; 24.7%) and systemic therapy (cervical, 53.3%; endometrial, 26.1%). Mean per patient per month costs per LOT were pre-treatment (cervical, US$17,210; endometrial, US$14,601), LOT1 (cervical, US$10,929; endometrial, US$6859), LOT2 (cervical, US$15,183; endometrial, US$10,649) and LOT3+ (cervical, US$19,681; endometrial, US$9206).
Conclusion
Overall, newly diagnosed patients with cervical or endometrial cancer received guideline-recommended treatment. Outpatient visits mainly drove healthcare costs across LOTs.
Authors
C Nwankwo, R Shah, A Shah, S Corman, N Kebede
Journal
Future oncology (London, England)
Therapeutic Area
Oncology
Center of Excellence
Real-world Evidence & Data Analytics
Year
https://pubmed.ncbi.nlm.nih.gov/35105169/
Read full article